In rats with short bowel syndrome, BPC-157 caused immediate weight gain and improved intestinal features following oral and intraperitoneal administration [17]

3.2 Study data 3.2.1 Studies with a control group One controlled study comparing polysomnography (PSG) data of children with GHD with age-matched controls found that children with GHD had significantly lower total sleep time, sleep efficiency, movement time, and time spent in rapid eye movement (REM) sleep and stage 2 non-REM sleep, plus a general decrease in electroencephalogram (EEG) arousability ( In another controlled study, a group of seven children with GHD underwent PSG before and after 12 weeks of GH therapy ( The third controlled study included five children with GHD and 10 healthy controls ( 3.2.2 Studies without a control group In a study evaluating GH secretion during sleep in children with short stature, peaks of GH secretion were found to occur primarily during slow-wave and deep sleep ( There were several inconsistencies in the findings of the identified studies

If 1,000 mcg of peptide is dissolved in 2 mL of bacteriostatic water, the concentration is calculated like this: Concentration = Total peptide amount Total solution volume 1,000 mcg 2 mL = 500 mcg/mL This means each milliliter of solution contains 500 mcg of peptide
Suggested Use : Take one capsule twice per day, or as recommended by your healthcare provider
BPC 157 has shown to have strong anti-inflammatory properties by inhibiting specific pathways involved in the inflammatory response
In gastrointestinal injury models, the peptide has been shown to support faster restoration of the intestinal mucosa and to reduce intestinal permeability